IBM shares dropped despite landing a Swiss quantum lab and releasing a NASA-backed lunar AI model. Investors are questioning whether new tech partnerships can offset falling mainframe sales and revive the stock's momentum
IBM's stock closed down 2.47% at $234.02 on September 10, even as the company announced two prominent partnerships in quantum computing and artificial intelligence. The market's response was clear: investors remain skeptical that IBM's latest government-backed technology initiatives can offset a significant decline in its core hardware business.
The NASA-IBM Lunar Foundation Model was trained primarily on data from the Lunar Reconnaissance Orbiter and is publicly available for experimentation on Hugging Face and GitHub.
Hardware slide and investor skepticism
The primary factor weighing on IBM's valuation is not a lack of innovation, but a steep decline in mainframe sales. IBM Z mainframe revenue fell 42% last quarter, dragging the broader infrastructure segment down 7%. CEO Arvind Krishna has acknowledged the company's slow adaptation, and the market has responded accordingly: IBM shares now trade nearly 30% below their 2026 high of $332.46. The sharpest single-day drop occurred in July, marking a decades-long record for IBM's volatility.
Wall Street analysts remain divided. Evercore ISI's Amit Daryanani notes that at current prices, investors are effectively getting IBM's quantum business for free. The company's quantum backlog has surpassed $1 billion and continues to grow each quarter, but this momentum is not reflected in the mainframe numbers that dominate earnings reports. The next key moment will be IBM's October 21 earnings release, when investors will assess whether hardware sales have stabilized or if new technology revenue can begin to offset legacy declines.
Quantum lab as political currency
IBM and Lockheed Martin announced on September 10, 2026, the creation of the Swiss Quantum Innovation Hub at ETH Zurich, which will host Switzerland's first IBM Quantum System Two. The project is part of a $3 billion offset obligation linked to the F-35A fighter jet contract, with the quantum system expected to be operational by the end of 2026.
This structure could serve as a model for future defense contracts. Finland's $10 billion F-35 agreement includes a similar offset requirement, but has so far focused on assembly rather than research labs. If more governments adopt Switzerland's approach, IBM could benefit from a steady stream of quantum installations funded by political necessity rather than competitive bidding-a revenue channel largely inaccessible to most commercial competitors.
Lunar AI and dual-use technology
The NASA IBM Lunar Foundation Model, released the same day as the Swiss quantum announcement, is trained on decades of lunar data and outperforms existing methods by up to 23% in identifying ice and craters. The model is open-source and operates on TerraTorch, IBM's geospatial AI toolkit. While its immediate application is civilian-supporting NASA's Artemis program-the technology also has potential value for defense satellite analysis. IBM is developing a unified platform, licensing access across sectors rather than building separate AI stacks for each customer.
For investors, the open-source strategy raises questions about monetization. IBM's approach is to introduce foundational models and toolkits to the market, then capture value through enterprise licensing and government contracts. The company maintains a 2.89% annualized dividend yield, providing some income stability as it transitions away from legacy hardware.
Market context and the path forward
IBM's dual announcements come as Wall Street increasingly demands clear evidence of revenue growth, not just technological achievements. As previously reported, capital is flowing to tech infrastructure only when there is a clear path to scalable, funded deployment. IBM's ability to convert government obligations into recurring technology revenue is a tactical advantage, but it does not eliminate the risk posed by declining mainframe sales.
According to stockanalysis.com, 25 analysts currently rate IBM a Buy, with a 12-month price target of $245.35-just under 5% above current levels. The company's dividend yield and government contracts offer a degree of stability, but the central question remains whether quantum and AI revenue can eventually outweigh the drag from legacy hardware. Until IBM demonstrates that its new initiatives deliver sustained growth, the stock is likely to remain under pressure, regardless of high-profile partnerships.
IBM's recent actions reflect a company leveraging every available channel-political, scientific, and commercial-to maintain relevance in a market that prioritizes measurable results. Investors should look beyond the next earnings report for signs that IBM's government-backed technology pipeline is more than a temporary solution for declining mainframe demand. The company's future depends on whether these unconventional deals can be scaled and monetized before investor patience is exhausted.
IBM's quantum computing strategy highlights the increasing importance of government-funded technology in shaping the competitive landscape. Unlike traditional commercial sales, offset agreements and public sector partnerships can provide stable, long-term revenue streams that are less sensitive to market cycles. However, these deals often come with political conditions and limited pricing flexibility. For investors, understanding the mechanics of government technology procurement-and how companies like IBM capitalize on them-can be as critical as tracking product launches or quarterly sales figures.
